Sucralfate
- Product NDC
- 50090-8157
- 11-digit product format
- 500908157
- Labeler code
- 50090
- Product ID
- 50090-8157_e87608f6-c02f-4021-ba7b-21b3dcfea91c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sucralfate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA215705
- Marketing category
- ANDA
- Marketing start
- 2023-05-20
- Substance
- SUCRALFATE
- Active strength
- 1 g/1
- Pharmacologic classes
- Aluminum Complex [EPC], Organometallic Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215705-001 | SUCRALFATE | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A215705-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | 3f0d92c62455… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215705-001 | SUCRALFATE | 1GM | TABLET / ORAL | AB | 2023-05-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A215705-001 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A215705-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A215705-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A215705-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215705-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A215705-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215705-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215705-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215705-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215705-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215705-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215705-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A215705-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215705-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215705-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215705-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A215705-001 | AB | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A215705-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A215705-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A215705-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A215705-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A215705-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A215705-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A215705-001 | AB | 1 | 3f0d92c62455… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215705-001 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sucralfate | SUCRALFATE | Zydus Lifesciences Limited | 882b7596-f62c-4be2-8f67-e64310718baa | 2026-08-08 | Adverse reactions | 215705 ANDA215705 |
| Sucralfate | SUCRALFATE | Viona Pharmaceuticals Inc | c708201b-2618-4470-a3ff-8ecf04d6b3a0 | 2026-08-08 | Adverse reactions | 215705 ANDA215705 |
| Sucralfate | SUCRALFATE | NCS HealthCare of KY, LLC dba Vangard Labs | 3b0259fa-806f-44c1-8deb-c11dbd84582d | 2026-06-24 | Adverse reactions | 215705 ANDA215705 |
| Sucralfate | SUCRALFATE | Preferred Pharmaceuticals Inc | a434bf8f-cc60-4d84-a9a4-61c3ff6b700e | 2026-01-21 | Adverse reactions | 215705 ANDA215705 |
| Sucralfate | SUCRALFATE | Redpharm Drug | 3251e156-4c52-63b3-e063-6294a90a9a95 | 2025-12-18 | Adverse reactions | 215705 ANDA215705 |
| Sucralfate | SUCRALFATE | NuCare Pharmaceuticals, Inc. | 31a7dcd0-e677-249a-e063-6294a90a75f6 | 2025-03-19 | Adverse reactions | 215705 ANDA215705 |
| Sucralfate | SUCRALFATE | Coupler LLC | 2d586736-73ae-9af0-e063-6294a90ad875 | 2025-02-04 | Adverse reactions | 215705 ANDA215705 |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | a068e818-8da3-4f0d-88e0-acc88e76f3aa | 2024-08-22 | Adverse reactions | 215705 ANDA215705 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-8157-0 | 50090815700 | 60 TABLET in 1 BOTTLE (50090-8157-0) | 60 tablet | 2026-10-14 | No | No | Historical |